Public trial registry of the CCC-Munich

Trial CLL 10

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CLL 10
World
Full title
:

Phase-III-Studie einer kombinierten Immunchemotherapie von Fludarabin, Cyclophosphamid und Rituximab (FCR) versus Bendamustin und Rituximab (BR) bei unbehandelten Patienten mit Chronisch Lymphatischer Leukämie

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C91.1- Chronische lymphatische Leukämie vom B-Zell-Typ [CLL]
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - reference number
:
08/064
World
PEI - vote
:
Positive
World
PEI - reference number
:
649/07
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.